Zusätzliche MET-Inhibition in der Zweitlinientherapie
Crossref DOI link: https://doi.org/10.1007/s15004-016-5337-5
Published Online: 2016-05-25
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schalhorn, Andreas
Text and Data Mining valid from 2016-05-25
